Difficulty: Medium
Average Score: 71%
Practice
Metabolic derangement secondary to tumor lysis syndrome in children includes all the following EXCEPT
Correct answer
B
Rationale
In pediatric oncology, tumor lysis syndrome (TLS) is a potentially life-threatening complication that can occur after initiating chemotherapy. Metabolic derangements in TLS result from the rapid release of intracellular contents into the bloodstream. The correct answer, B) hypernatremia, is not typically associated with TLS in children.
A) Hyperuricemia is a common finding in TLS due to the release of uric acid from lysed cells. C) Hyperkalemia occurs as potassium is released from damaged cells, leading to potential cardiac arrhythmias. D) Hyperphosphatemia is also a hallmark of TLS, as phosphorus is released from lysed cells, potentially causing renal damage.
Educationally, understanding the metabolic effects of TLS is crucial for nurses caring for pediatric oncology patients. Recognizing these electrolyte imbalances promptly can guide appropriate interventions to prevent complications such as renal failure or cardiac arrhythmias. Nurses play a vital role in monitoring, assessing, and managing TLS in collaboration with the healthcare team to ensure the best outcomes for pediatric patients undergoing cancer treatment.
A) Hyperuricemia is a common finding in TLS due to the release of uric acid from lysed cells. C) Hyperkalemia occurs as potassium is released from damaged cells, leading to potential cardiac arrhythmias. D) Hyperphosphatemia is also a hallmark of TLS, as phosphorus is released from lysed cells, potentially causing renal damage.
Educationally, understanding the metabolic effects of TLS is crucial for nurses caring for pediatric oncology patients. Recognizing these electrolyte imbalances promptly can guide appropriate interventions to prevent complications such as renal failure or cardiac arrhythmias. Nurses play a vital role in monitoring, assessing, and managing TLS in collaboration with the healthcare team to ensure the best outcomes for pediatric patients undergoing cancer treatment.